We investigate bioaccessibility and bioavailability via various administration routes, using in vivo, as well as in vitro techniques, including TNO’s famous patented in vitro models of the GI-tract, TIM. In the area of formulation development, we specialize in polysaccharide-based matrices for proteins, peptides and small chemical molecules with site-specific or on-demand release characteristics.